In conclusion, to our knowledge, our patient is the first case with SHILCA syndrome caused by the compound heterozygosity of the already reported Alu-mediated NMNAT1 duplication and a novel splicing pathogenic variant. This evidence concerns the gene NMNAT1 and spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis.